Table 2.
The seroprevalence of Toxoplasma gondii in patients with various hepatic disorders in China
| Clinical disease | Patients with anti-T. gondii IgG antibodies | |||
|---|---|---|---|---|
| No. tested | No. positive (%) | OR (95% CI) | P-value | |
| None | 1003 | 139 (13·86) | Reference | – |
| Liver cirrhosis | 267 | 66 (24·72) | 2·05 (1·46–2·86) | <0·001 |
| Hepatitis | 259 | 67 (25·87) | 1·85 (1·34–2·56) | <0·001 |
| Liver cancer | 199 | 54 (27·14) | 2·48 (1·69–3·65) | <0·001 |
| Steatosis | 167 | 38 (22·75) | 1·59 (1·06–3·39) | 0·02 |
| Other1 | 25 | 0 (0) | – | – |
| Total | 1920 | 364 (18·96) | 1·91 (1·51–2·42) | <0·001 |
OR, odds ratio; CI, confidence interval.
1
Include amoebic liver abscess, hepatic hemangioma, hepatic cyst, focal liver lesions, and hepatocellular liver disease.